Aspirin in the treatment of sexual dysfunction

Evaluation of Aspirin efficacy in prevention of erectile dysfunction due to lithium administration in comparison with placebo

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT138711131556N4

Enrollment

Registered

2009-02-12

Start date

2009-02-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual dysfunction. Sexual dysfunction, not caused by organic disorder or disease

Interventions

Intervention 1: Asprin (80 mg TDS) as intervention group. Intervention 2: Tab Placebo as control group.

Treatment - Drugs

Asprin (80 mg TDS) as intervention group

Tab Placebo as control group

Eligibility

Sex/Gender

Male

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Remission phase of bipolar disorder, maintenance on lithium, sexual dysfunction based on international index of erectile function. Exclusion Criteria: Other psychiatric comorbidity, substance dependence, GI bleeding.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Score of international index of erectile function. Timepoint: every two week. Method of measurement: use of international index of erectile function.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026